» Articles » PMID: 38868036

Effects of Peripheral Blood Cells on Ischemic Stroke: Greater Immune Response or Systemic Inflammation?

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Jun 13
PMID 38868036
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic stroke is still one of the most serious medical conditions endangering human health worldwide. Current research on the mechanism of ischemic stroke focuses on the primary etiology as well as the subsequent inflammatory response and immune modulation. Recent research has revealed that peripheral blood cells and their components are crucial to the ensuing progression of ischemic stroke. However, it remains unclear whether blood cell elements are principally in charge of systemic inflammation or immunological regulation, or if their participation is beneficial or harmful to the development of ischemic stroke. In this review, we aim to describe the changes in peripheral blood cells and their corresponding parameters in ischemic stroke. Specifically, we elaborate on the role of each peripheral component in the inflammatory response or immunological modulation as well as their interactions. It has been suggested that more specific therapies aimed at targeting peripheral blood cell components and their role in inflammation or immunity are more favorable to the treatment of ischemic stroke.

Citing Articles

Inhibition of IL-6 trans-signaling promotes post-stroke functional recovery in a sex and dose-dependent manner.

Hall C, Nguyen D, Mendoza K, Tan C, Chauhan A J Neuroinflammation. 2025; 22(1):52.

PMID: 40011978 PMC: 11866694. DOI: 10.1186/s12974-025-03365-y.


Association of Six Complex Inflammatory Indicators with Prognosis in Patients with Intravenous Thrombolysis Stroke.

Li Y, Xi L, Sun H, Yu F, Liang Q, Qie T Int J Gen Med. 2024; 17:5511-5521.

PMID: 39619134 PMC: 11608057. DOI: 10.2147/IJGM.S489482.

References
1.
Park J, Chang J, Kim J, Lee J . Monocyte Transmodulation: The Next Novel Therapeutic Approach in Overcoming Ischemic Stroke?. Front Neurol. 2020; 11:578003. PMC: 7642685. DOI: 10.3389/fneur.2020.578003. View

2.
Mehta S, Bassand J, Chrolavicius S, Diaz R, Eikelboom J, Fox K . Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010; 363(10):930-42. DOI: 10.1056/NEJMoa0909475. View

3.
DeGraba T . The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology. 1998; 51(3 Suppl 3):S62-8. DOI: 10.1212/wnl.51.3_suppl_3.s62. View

4.
Remigante A, Morabito R, Marino A . Band 3 protein function and oxidative stress in erythrocytes. J Cell Physiol. 2021; 236(9):6225-6234. DOI: 10.1002/jcp.30322. View

5.
Kotfis K, Bott-Olejnik M, Szylinska A, Rotter I . Could Neutrophil-to-Lymphocyte Ratio (NLR) Serve as a Potential Marker for Delirium Prediction in Patients with Acute Ischemic Stroke? A Prospective Observational Study. J Clin Med. 2019; 8(7). PMC: 6679160. DOI: 10.3390/jcm8071075. View